HUAYOU COBALT(SH:603799) Xuan Gu Bao·2025-09-29 12:18Suspension and Resumption of Trading - Baicheng Co., Ltd. plans to acquire 55% of Shanghai Canxi Engineering Equipment Co., Ltd., resulting in stock suspension [1] - DiAo Micro plans to acquire equity in Rongpai Semiconductor (Shanghai) Co., Ltd., leading to stock suspension [2] Mergers and Acquisitions - Fulian Precision plans to jointly increase capital in its subsidiary Jiangxi Shenghua with CATL, with Fulian investing 1 billion yuan and CATL investing 2.563 billion yuan, resulting in shareholding of 51% for CATL and 47.41% for Fulian [3] - Bohai Automobile intends to purchase 51% of Beijing Beiqi Mould Technology Co., Ltd., 51% of Haina Chuan Andotuo (Langfang) Seat Co., Ltd., 100% of Inafa Intelligent Technology (Beijing) Co., Ltd., and 50% of Langfang Laini Wiring System Co., Ltd. through share issuance and cash payment [4] - Huamao Technology plans to acquire the remaining 57.84% equity of Fuchuang Youyue [5] - Guolin Technology intends to purchase 91.07% of Kailianjie in cash [6] - Jingye Intelligent plans to acquire 51% of Hefei Shengwen for 108 million yuan in cash [7] Share Buybacks - CIMC plans to use 300 million to 500 million yuan of its own funds to repurchase company shares [8] - Hanshuo Technology intends to repurchase shares worth 150 million to 300 million yuan [9] Investment Cooperation and Operational Status - Zhongwei Co., Ltd. signed a strategic cooperation framework agreement with Xiamen Tungsten New Energy to collaborate on key battery material supply chains in emerging fields like robotics [10] - Hubei Energy signed a deepening cooperation agreement with the Xiangyang Municipal Government, investing 26.7 billion yuan [11] - CRRC signed several major contracts from July to September, totaling approximately 54.34 billion yuan [12] - Huayou Cobalt's subsidiary signed a sales contract for 76,000 tons of ternary precursors with LGES [13] - Jiufeng Energy plans to invest up to 3.455 billion yuan in a coal-to-natural gas project in Xinjiang [14] - Shengmei Shanghai reported a total order amount of 9.072 billion yuan as of September 29, 2025, an increase of 34.10% year-on-year [15] - Wharton Technology plans to invest in membrane materials and membrane component capacity enhancement projects [16] - Kangchen Pharmaceutical received a clinical trial notification for KC1036 combined with PD-1 antibody and platinum-based chemotherapy for advanced recurrent or metastatic esophageal squamous cell carcinoma [17] Performance Changes - Yinglian Co., Ltd. expects a net profit of 34.5 million to 37.5 million yuan for the first three quarters, an increase of 1531.13% to 1672.97% year-on-year, driven by improvements in the metal packaging sector [18] - Dalian Heavy Industry anticipates a net profit of 474 million to 508 million yuan for the first three quarters, a year-on-year increase of 19.91% to 28.52%, primarily due to steady revenue growth [19]